您的购物车当前为空
别名 CDC, 3,4-二羟基-α-氰基肉桂酸肉桂基酯
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate(CDC)是一种强效 12/15-脂氧合酶(12/15-LO)抑制剂(IC50 = 9-25nm),可用于 1 型糖尿病研究。

Cinnamyl-3,4-dihydroxy-α-cyanocinnamate(CDC)是一种强效 12/15-脂氧合酶(12/15-LO)抑制剂(IC50 = 9-25nm),可用于 1 型糖尿病研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 599 | In Stock |
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate 相关产品
| 产品描述 | Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-lipoxygenase (12/15-LO) inhibitor (IC50 = 9-25nm), studied for type 1 diabetes. |
| 体外活性 | High glucose or 12(S)-HETE remarkably increased transendothelial dextran transport, and in combination it was increased further. Addition of the 12/15-LO inhibitor, CDC, partially suppressed dextran transport [1]. |
| 体内活性 | The high glucose and 12(S)-hydroxyeicosatetraenoic acid (HETE) could alter vascular endothelial (VE)-cadherin and β‐catenin phosphorylation levels, but did not alter total protein expression. However, the 12/15-LO inhibitor, Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC), antagonized the effect of high glucose on protein phosphorylation to mitigate destruction of the endothelial cell barrier, and the mouse diabetes mellitus model further confirmed these conclusions [1]. |
| 别名 | CDC, 3,4-二羟基-α-氰基肉桂酸肉桂基酯 |
| 分子量 | 321.33 |
| 分子式 | C19H15NO4 |
| CAS No. | 132465-11-3 |
| Smiles | Oc1ccc(\C=C(/C#N)C(=O)OC\C=C\c2ccccc2)cc1O |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 40 mg/mL (124.48 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.22 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容